It is also possible that increased systemic expression of IL-33 and IL1RL2 could be attributed to the patient’s adaptive immune responses to minimize infection associated with the infiltration of bacteria into the periprosthetic tissue from the percutaneous stoma. Here, IL33 is linked to infection.